Levodopa/Carbidopa/Entacapon G.L. Pharma

Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone G.L. Pharma, is an antiparkinson agent presented as an oral tablet for oral use. It is combined with levodopa and carbidopa to treat Parkinson's disease and motor fluctuations in patients with Parkinson's disease.

GNH USA supplies Levodopa/Carbidopa/Entacapone G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Levodopa/Carbidopa/Entacapone is used in the management of Parkinsonian disorders, targeting motor symptoms and fluctuations.

- Parkinson's disease: improves overall motor function by increasing central dopamine availability. - Motor fluctuations in Parkinson's disease: reduces off‑time and extends on‑time periods. - Parkinsonian tremor: helps control tremor and rigidity associated with the disease.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea: upset stomach and feeling of sickness. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate head pain. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that can cause fainting. - Dyskinesia: involuntary, erratic movements that may be disabling. - Hepatic dysfunction: abnormal liver enzymes or liver injury. - Allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, several safety considerations should be reviewed.

- Monitor blood pressure: watch for orthostatic hypotension, especially during dose titration. - Assess liver function: entacapone can affect hepatic enzymes; periodic testing is advised. - Evaluate psychiatric status: the medication may exacerbate hallucinations or confusion. - Review concomitant MAO‑B inhibitors: combined use can increase risk of hypertensive events. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

Levodopa/Carbidopa/Entacapone can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may cause hypertensive crisis when combined. - Anticholinergic agents: can increase confusion and cognitive impairment.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: additive blood‑pressure lowering effect. - SSRIs or SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: may reduce levodopa absorption if taken simultaneously.